September 2006

Table of contents

Research
- The endocannabinoid system receptor CB1 blocker – a new possibility in the management of metabolic syndrome
Review
- Metabolic syndrome – the nature and pathogenesis
- A general ethical framework for biomedical research involving human subjects
Case history
- HELLP syndrome